nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—breast cancer—Dexamethasone—psoriasis	0.18	0.5	CpDpCtD
Conjugated Estrogens—breast cancer—Betamethasone—psoriasis	0.18	0.5	CpDpCtD
Conjugated Estrogens—Exemestane—Prednisone—psoriasis	0.0594	0.339	CrCrCtD
Conjugated Estrogens—Exemestane—Prednisolone—psoriasis	0.0579	0.331	CrCrCtD
Conjugated Estrogens—Formestane—Hydrocortisone—psoriasis	0.0577	0.33	CrCrCtD
Conjugated Estrogens—ABCC11—Methotrexate—psoriasis	0.0288	0.0828	CbGbCtD
Conjugated Estrogens—SLC10A1—Cyclosporine—psoriasis	0.027	0.0777	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—psoriasis	0.0198	0.0568	CbGbCtD
Conjugated Estrogens—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0176	0.0506	CbGbCtD
Conjugated Estrogens—ABCC3—Cyclosporine—psoriasis	0.015	0.0432	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—psoriasis	0.0126	0.0363	CbGbCtD
Conjugated Estrogens—CYP1A2—Clobetasol propionate—psoriasis	0.0111	0.032	CbGbCtD
Conjugated Estrogens—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0102	0.0295	CbGbCtD
Conjugated Estrogens—ABCC1—Cyclosporine—psoriasis	0.00922	0.0265	CbGbCtD
Conjugated Estrogens—SLCO1A2—Prednisolone—psoriasis	0.0092	0.0264	CbGbCtD
Conjugated Estrogens—ABCC2—Mycophenolate mofetil—psoriasis	0.00901	0.0259	CbGbCtD
Conjugated Estrogens—SLCO1A2—Hydrocortisone—psoriasis	0.00872	0.0251	CbGbCtD
Conjugated Estrogens—SLCO1A2—Prednisone—psoriasis	0.00868	0.025	CbGbCtD
Conjugated Estrogens—SLCO1A2—Cyclosporine—psoriasis	0.00823	0.0237	CbGbCtD
Conjugated Estrogens—ABCG2—Mycophenolate mofetil—psoriasis	0.00814	0.0234	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—psoriasis	0.00795	0.0228	CbGbCtD
Conjugated Estrogens—SLCO1B1—Cyclosporine—psoriasis	0.00777	0.0223	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—psoriasis	0.00706	0.0203	CbGbCtD
Conjugated Estrogens—ABCC2—Cyclosporine—psoriasis	0.00683	0.0196	CbGbCtD
Conjugated Estrogens—ABCG2—Hydrocortisone—psoriasis	0.00653	0.0188	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—psoriasis	0.00652	0.0188	CbGbCtD
Conjugated Estrogens—ABCG2—Cyclosporine—psoriasis	0.00617	0.0177	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—psoriasis	0.00607	0.0175	CbGbCtD
Conjugated Estrogens—CYP1A2—Methoxsalen—psoriasis	0.00585	0.0168	CbGbCtD
Conjugated Estrogens—SLCO1A2—Dexamethasone—psoriasis	0.00542	0.0156	CbGbCtD
Conjugated Estrogens—SLC22A6—Cyclosporine—psoriasis	0.00499	0.0144	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—psoriasis	0.00488	0.014	CbGbCtD
Conjugated Estrogens—ABCC2—Dexamethasone—psoriasis	0.00449	0.0129	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—psoriasis	0.00436	0.0125	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—psoriasis	0.00411	0.0118	CbGbCtD
Conjugated Estrogens—ABCG2—Dexamethasone—psoriasis	0.00406	0.0117	CbGbCtD
Conjugated Estrogens—CYP3A4—Calcitriol—psoriasis	0.00394	0.0113	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—psoriasis	0.00379	0.0109	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—psoriasis	0.00361	0.0104	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—psoriasis	0.00327	0.00939	CbGbCtD
Conjugated Estrogens—CYP3A4—Methoxsalen—psoriasis	0.00306	0.0088	CbGbCtD
Conjugated Estrogens—ABCB1—Mycophenolate mofetil—psoriasis	0.00294	0.00844	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—psoriasis	0.00264	0.0076	CbGbCtD
Conjugated Estrogens—ABCB1—Betamethasone—psoriasis	0.00252	0.00724	CbGbCtD
Conjugated Estrogens—ABCB1—Prednisolone—psoriasis	0.00249	0.00714	CbGbCtD
Conjugated Estrogens—ABCB1—Hydrocortisone—psoriasis	0.00236	0.00677	CbGbCtD
Conjugated Estrogens—ABCB1—Prednisone—psoriasis	0.00235	0.00675	CbGbCtD
Conjugated Estrogens—ABCB1—Cyclosporine—psoriasis	0.00222	0.0064	CbGbCtD
Conjugated Estrogens—CYP3A4—Cholecalciferol—psoriasis	0.00203	0.00583	CbGbCtD
Conjugated Estrogens—CYP3A4—Triamcinolone—psoriasis	0.00176	0.00506	CbGbCtD
Conjugated Estrogens—CYP3A4—Mycophenolate mofetil—psoriasis	0.00176	0.00506	CbGbCtD
Conjugated Estrogens—CYP3A4—Betamethasone—psoriasis	0.00151	0.00434	CbGbCtD
Conjugated Estrogens—CYP3A4—Prednisolone—psoriasis	0.00149	0.00428	CbGbCtD
Conjugated Estrogens—ABCB1—Dexamethasone—psoriasis	0.00147	0.00421	CbGbCtD
Conjugated Estrogens—CYP3A4—Hydrocortisone—psoriasis	0.00141	0.00406	CbGbCtD
Conjugated Estrogens—CYP3A4—Prednisone—psoriasis	0.00141	0.00404	CbGbCtD
Conjugated Estrogens—CYP3A4—Cyclosporine—psoriasis	0.00133	0.00383	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—psoriasis	0.00118	0.00338	CbGbCtD
Conjugated Estrogens—CYP3A4—Dexamethasone—psoriasis	0.000878	0.00252	CbGbCtD
Conjugated Estrogens—ABCB1—Allograft Rejection—HLA-C—psoriasis	3.47e-05	0.00256	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—IL13—psoriasis	3.45e-05	0.00254	CbGpPWpGaD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—CARM1—psoriasis	3.41e-05	0.00252	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—CYP2S1—psoriasis	3.31e-05	0.00244	CbGpPWpGaD
Conjugated Estrogens—ESR1—FOXA1 transcription factor network—JUN—psoriasis	3.31e-05	0.00244	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	3.29e-05	0.00243	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Biological oxidations—CYP2S1—psoriasis	3.26e-05	0.0024	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	3.21e-05	0.00237	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	3.21e-05	0.00236	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—IL17A—psoriasis	3.17e-05	0.00234	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	3.16e-05	0.00233	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.07e-05	0.00227	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.06e-05	0.00226	CbGpPWpGaD
Conjugated Estrogens—Hepatobiliary disease—Methotrexate—psoriasis	3.05e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Cyclosporine—psoriasis	3.04e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Betamethasone—psoriasis	3.04e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Dexamethasone—psoriasis	3.04e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Dizziness—Mycophenolic acid—psoriasis	3.04e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Prednisolone—psoriasis	3.04e-05	0.000293	CcSEcCtD
Conjugated Estrogens—Tachycardia—Triamcinolone—psoriasis	3.04e-05	0.000292	CcSEcCtD
Conjugated Estrogens—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.03e-05	0.00224	CbGpPWpGaD
Conjugated Estrogens—Mental disorder—Prednisone—psoriasis	3.03e-05	0.000292	CcSEcCtD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	3.03e-05	0.00223	CbGpPWpGaD
Conjugated Estrogens—Erythema—Prednisone—psoriasis	3.01e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Malnutrition—Prednisone—psoriasis	3.01e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.01e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Triamcinolone—psoriasis	3.01e-05	0.00029	CcSEcCtD
Conjugated Estrogens—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	3e-05	0.00221	CbGpPWpGaD
Conjugated Estrogens—Convulsion—Dexamethasone—psoriasis	3e-05	0.000289	CcSEcCtD
Conjugated Estrogens—Convulsion—Betamethasone—psoriasis	3e-05	0.000289	CcSEcCtD
Conjugated Estrogens—Insomnia—Hydrocortisone—psoriasis	2.99e-05	0.000288	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—NDUFA5—psoriasis	2.98e-05	0.0022	CbGpPWpGaD
Conjugated Estrogens—Paraesthesia—Hydrocortisone—psoriasis	2.97e-05	0.000286	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	2.96e-05	0.000286	CcSEcCtD
Conjugated Estrogens—Urticaria—Cyclosporine—psoriasis	2.95e-05	0.000284	CcSEcCtD
Conjugated Estrogens—ABCB1—Allograft Rejection—IL12B—psoriasis	2.95e-05	0.00218	CbGpPWpGaD
Conjugated Estrogens—Myalgia—Dexamethasone—psoriasis	2.94e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Myalgia—Betamethasone—psoriasis	2.94e-05	0.000284	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Cyclosporine—psoriasis	2.94e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cyclosporine—psoriasis	2.94e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Anxiety—Dexamethasone—psoriasis	2.93e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Anxiety—Betamethasone—psoriasis	2.93e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Vomiting—Mycophenolic acid—psoriasis	2.92e-05	0.000281	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Hydrocortisone—psoriasis	2.91e-05	0.00028	CcSEcCtD
Conjugated Estrogens—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	2.9e-05	0.00214	CbGpPWpGaD
Conjugated Estrogens—Rash—Mycophenolic acid—psoriasis	2.9e-05	0.000279	CcSEcCtD
Conjugated Estrogens—Dermatitis—Mycophenolic acid—psoriasis	2.89e-05	0.000279	CcSEcCtD
Conjugated Estrogens—Pain—Prednisolone—psoriasis	2.89e-05	0.000279	CcSEcCtD
Conjugated Estrogens—Urticaria—Mycophenolate mofetil—psoriasis	2.88e-05	0.000277	CcSEcCtD
Conjugated Estrogens—ABCB1—Allograft Rejection—HLA-E—psoriasis	2.88e-05	0.00212	CbGpPWpGaD
Conjugated Estrogens—Headache—Mycophenolic acid—psoriasis	2.88e-05	0.000277	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Hydrocortisone—psoriasis	2.87e-05	0.000277	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—psoriasis	2.87e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Mycophenolate mofetil—psoriasis	2.87e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Mycophenolate mofetil—psoriasis	2.87e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.85e-05	0.000275	CcSEcCtD
Conjugated Estrogens—Fatigue—Hydrocortisone—psoriasis	2.85e-05	0.000274	CcSEcCtD
Conjugated Estrogens—Vision blurred—Prednisone—psoriasis	2.84e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Triamcinolone—psoriasis	2.83e-05	0.000273	CcSEcCtD
Conjugated Estrogens—Pain—Hydrocortisone—psoriasis	2.82e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Oedema—Betamethasone—psoriasis	2.82e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Betamethasone—psoriasis	2.82e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Dexamethasone—psoriasis	2.82e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Oedema—Dexamethasone—psoriasis	2.82e-05	0.000272	CcSEcCtD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	2.81e-05	0.00208	CbGpPWpGaD
Conjugated Estrogens—Insomnia—Triamcinolone—psoriasis	2.81e-05	0.000271	CcSEcCtD
Conjugated Estrogens—CYP1A2—Tryptophan metabolism—CAT—psoriasis	2.81e-05	0.00207	CbGpPWpGaD
Conjugated Estrogens—Infection—Dexamethasone—psoriasis	2.8e-05	0.00027	CcSEcCtD
Conjugated Estrogens—Infection—Betamethasone—psoriasis	2.8e-05	0.00027	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Triamcinolone—psoriasis	2.79e-05	0.000269	CcSEcCtD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.79e-05	0.00206	CbGpPWpGaD
Conjugated Estrogens—Visual impairment—Methotrexate—psoriasis	2.79e-05	0.000268	CcSEcCtD
Conjugated Estrogens—Shock—Dexamethasone—psoriasis	2.78e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Shock—Betamethasone—psoriasis	2.78e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Triamcinolone—psoriasis	2.77e-05	0.000267	CcSEcCtD
Conjugated Estrogens—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	2.77e-05	0.00204	CbGpPWpGaD
Conjugated Estrogens—Nervous system disorder—Betamethasone—psoriasis	2.77e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Dexamethasone—psoriasis	2.77e-05	0.000267	CcSEcCtD
Conjugated Estrogens—Tachycardia—Dexamethasone—psoriasis	2.75e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Tachycardia—Betamethasone—psoriasis	2.75e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Angioedema—Prednisone—psoriasis	2.75e-05	0.000265	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cyclosporine—psoriasis	2.74e-05	0.000264	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Triamcinolone—psoriasis	2.74e-05	0.000264	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—psoriasis	2.73e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Nausea—Mycophenolic acid—psoriasis	2.73e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Betamethasone—psoriasis	2.73e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Dexamethasone—psoriasis	2.73e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Vertigo—Prednisone—psoriasis	2.71e-05	0.000261	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of Telomerase—IFNG—psoriasis	2.7e-05	0.00199	CbGpPWpGaD
Conjugated Estrogens—Eye disorder—Methotrexate—psoriasis	2.7e-05	0.00026	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Hydrocortisone—psoriasis	2.7e-05	0.00026	CcSEcCtD
Conjugated Estrogens—Syncope—Prednisone—psoriasis	2.7e-05	0.00026	CcSEcCtD
Conjugated Estrogens—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	2.69e-05	0.00198	CbGpPWpGaD
Conjugated Estrogens—Anorexia—Betamethasone—psoriasis	2.69e-05	0.000259	CcSEcCtD
Conjugated Estrogens—Anorexia—Dexamethasone—psoriasis	2.69e-05	0.000259	CcSEcCtD
Conjugated Estrogens—Urticaria—Prednisolone—psoriasis	2.69e-05	0.000259	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—psoriasis	2.68e-05	0.000258	CcSEcCtD
Conjugated Estrogens—Fatigue—Triamcinolone—psoriasis	2.68e-05	0.000258	CcSEcCtD
Conjugated Estrogens—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.68e-05	0.00198	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.67e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Asthenia—Cyclosporine—psoriasis	2.67e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Pain—Triamcinolone—psoriasis	2.66e-05	0.000256	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Prednisone—psoriasis	2.65e-05	0.000255	CcSEcCtD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—IFNG—psoriasis	2.64e-05	0.00195	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Betamethasone—psoriasis	2.64e-05	0.000254	CcSEcCtD
Conjugated Estrogens—Hypotension—Dexamethasone—psoriasis	2.64e-05	0.000254	CcSEcCtD
Conjugated Estrogens—ESR1—Gene Expression—TARS—psoriasis	2.63e-05	0.00194	CbGpPWpGaD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	2.63e-05	0.00194	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Cyclosporine—psoriasis	2.63e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Urticaria—Hydrocortisone—psoriasis	2.62e-05	0.000253	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—psoriasis	2.62e-05	0.000253	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	2.62e-05	0.00193	CbGpPWpGaD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—JUN—psoriasis	2.62e-05	0.00193	CbGpPWpGaD
Conjugated Estrogens—Immune system disorder—Methotrexate—psoriasis	2.61e-05	0.000252	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Hydrocortisone—psoriasis	2.61e-05	0.000252	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Hydrocortisone—psoriasis	2.61e-05	0.000252	CcSEcCtD
Conjugated Estrogens—Convulsion—Prednisone—psoriasis	2.61e-05	0.000251	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—psoriasis	2.61e-05	0.000251	CcSEcCtD
Conjugated Estrogens—Asthenia—Mycophenolate mofetil—psoriasis	2.6e-05	0.000251	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Dexamethasone—psoriasis	2.57e-05	0.000248	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Betamethasone—psoriasis	2.57e-05	0.000248	CcSEcCtD
Conjugated Estrogens—Pruritus—Mycophenolate mofetil—psoriasis	2.56e-05	0.000247	CcSEcCtD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.56e-05	0.00189	CbGpPWpGaD
Conjugated Estrogens—Myalgia—Prednisone—psoriasis	2.56e-05	0.000247	CcSEcCtD
Conjugated Estrogens—Arthralgia—Prednisone—psoriasis	2.56e-05	0.000247	CcSEcCtD
Conjugated Estrogens—Anxiety—Prednisone—psoriasis	2.55e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—psoriasis	2.55e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Insomnia—Betamethasone—psoriasis	2.55e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Insomnia—Dexamethasone—psoriasis	2.55e-05	0.000246	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.55e-05	0.000245	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cyclosporine—psoriasis	2.54e-05	0.000245	CcSEcCtD
Conjugated Estrogens—COMT—Metabolism—CYP2S1—psoriasis	2.54e-05	0.00187	CbGpPWpGaD
Conjugated Estrogens—Paraesthesia—Dexamethasone—psoriasis	2.53e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Betamethasone—psoriasis	2.53e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—psoriasis	2.53e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—psoriasis	2.52e-05	0.000242	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—psoriasis	2.52e-05	0.000242	CcSEcCtD
Conjugated Estrogens—CYP3A4—Biological oxidations—CYP2S1—psoriasis	2.51e-05	0.00185	CbGpPWpGaD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	2.51e-05	0.00185	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Prednisolone—psoriasis	2.49e-05	0.00024	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Betamethasone—psoriasis	2.48e-05	0.000239	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Dexamethasone—psoriasis	2.48e-05	0.000239	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Mycophenolate mofetil—psoriasis	2.48e-05	0.000239	CcSEcCtD
Conjugated Estrogens—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	2.48e-05	0.00183	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Triamcinolone—psoriasis	2.47e-05	0.000238	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—psoriasis	2.46e-05	0.000237	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Triamcinolone—psoriasis	2.46e-05	0.000237	CcSEcCtD
Conjugated Estrogens—Dizziness—Cyclosporine—psoriasis	2.46e-05	0.000237	CcSEcCtD
Conjugated Estrogens—Oedema—Prednisone—psoriasis	2.46e-05	0.000237	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Prednisone—psoriasis	2.46e-05	0.000237	CcSEcCtD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	2.45e-05	0.00181	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Betamethasone—psoriasis	2.45e-05	0.000236	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Dexamethasone—psoriasis	2.45e-05	0.000236	CcSEcCtD
Conjugated Estrogens—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	2.45e-05	0.00181	CbGpPWpGaD
Conjugated Estrogens—Infection—Prednisone—psoriasis	2.44e-05	0.000235	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Metabolism—NDUFA5—psoriasis	2.44e-05	0.0018	CbGpPWpGaD
Conjugated Estrogens—Gastrointestinal disorder—Dexamethasone—psoriasis	2.44e-05	0.000235	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Betamethasone—psoriasis	2.44e-05	0.000235	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—psoriasis	2.43e-05	0.000234	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Hydrocortisone—psoriasis	2.43e-05	0.000234	CcSEcCtD
Conjugated Estrogens—Fatigue—Dexamethasone—psoriasis	2.43e-05	0.000234	CcSEcCtD
Conjugated Estrogens—Fatigue—Betamethasone—psoriasis	2.43e-05	0.000234	CcSEcCtD
Conjugated Estrogens—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.42e-05	0.00179	CbGpPWpGaD
Conjugated Estrogens—Shock—Prednisone—psoriasis	2.42e-05	0.000233	CcSEcCtD
Conjugated Estrogens—Pain—Dexamethasone—psoriasis	2.41e-05	0.000232	CcSEcCtD
Conjugated Estrogens—Pain—Betamethasone—psoriasis	2.41e-05	0.000232	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Prednisone—psoriasis	2.41e-05	0.000232	CcSEcCtD
Conjugated Estrogens—Tachycardia—Prednisone—psoriasis	2.4e-05	0.000231	CcSEcCtD
Conjugated Estrogens—Dizziness—Mycophenolate mofetil—psoriasis	2.4e-05	0.000231	CcSEcCtD
Conjugated Estrogens—ABCC4—Platelet degranulation—VEGFA—psoriasis	2.39e-05	0.00176	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.39e-05	0.00176	CbGpPWpGaD
Conjugated Estrogens—Skin disorder—Prednisone—psoriasis	2.39e-05	0.00023	CcSEcCtD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—JUN—psoriasis	2.38e-05	0.00176	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	2.38e-05	0.00176	CbGpPWpGaD
Conjugated Estrogens—Hyperhidrosis—Prednisone—psoriasis	2.38e-05	0.000229	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—psoriasis	2.37e-05	0.000228	CcSEcCtD
Conjugated Estrogens—Asthenia—Hydrocortisone—psoriasis	2.37e-05	0.000228	CcSEcCtD
Conjugated Estrogens—Vomiting—Cyclosporine—psoriasis	2.36e-05	0.000228	CcSEcCtD
Conjugated Estrogens—Rash—Cyclosporine—psoriasis	2.34e-05	0.000226	CcSEcCtD
Conjugated Estrogens—Anorexia—Prednisone—psoriasis	2.34e-05	0.000226	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cyclosporine—psoriasis	2.34e-05	0.000226	CcSEcCtD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	2.34e-05	0.00173	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Hydrocortisone—psoriasis	2.34e-05	0.000225	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of Telomerase—JUN—psoriasis	2.34e-05	0.00172	CbGpPWpGaD
Conjugated Estrogens—Headache—Cyclosporine—psoriasis	2.33e-05	0.000224	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Dexamethasone—psoriasis	2.31e-05	0.000222	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Betamethasone—psoriasis	2.31e-05	0.000222	CcSEcCtD
Conjugated Estrogens—Vomiting—Mycophenolate mofetil—psoriasis	2.3e-05	0.000222	CcSEcCtD
Conjugated Estrogens—ABCC4—Hemostasis—ITGAL—psoriasis	2.3e-05	0.0017	CbGpPWpGaD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.29e-05	0.00169	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Triamcinolone—psoriasis	2.29e-05	0.000221	CcSEcCtD
Conjugated Estrogens—Rash—Mycophenolate mofetil—psoriasis	2.29e-05	0.00022	CcSEcCtD
Conjugated Estrogens—Dermatitis—Mycophenolate mofetil—psoriasis	2.28e-05	0.00022	CcSEcCtD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—JUN—psoriasis	2.28e-05	0.00168	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.28e-05	0.00168	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.27e-05	0.00168	CbGpPWpGaD
Conjugated Estrogens—Headache—Mycophenolate mofetil—psoriasis	2.27e-05	0.000219	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	2.27e-05	0.00167	CbGpPWpGaD
Conjugated Estrogens—Vertigo—Methotrexate—psoriasis	2.26e-05	0.000218	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Hydrocortisone—psoriasis	2.26e-05	0.000218	CcSEcCtD
Conjugated Estrogens—ESR1—Regulation of Telomerase—NFKB1—psoriasis	2.25e-05	0.00166	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Betamethasone—psoriasis	2.24e-05	0.000216	CcSEcCtD
Conjugated Estrogens—Urticaria—Dexamethasone—psoriasis	2.24e-05	0.000216	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Prednisone—psoriasis	2.24e-05	0.000216	CcSEcCtD
Conjugated Estrogens—Dizziness—Prednisolone—psoriasis	2.24e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Asthenia—Triamcinolone—psoriasis	2.23e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Betamethasone—psoriasis	2.23e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Betamethasone—psoriasis	2.23e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Dexamethasone—psoriasis	2.23e-05	0.000215	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Dexamethasone—psoriasis	2.23e-05	0.000215	CcSEcCtD
Conjugated Estrogens—ESR1—LKB1 signaling events—TP53—psoriasis	2.22e-05	0.00164	CbGpPWpGaD
Conjugated Estrogens—Insomnia—Prednisone—psoriasis	2.22e-05	0.000214	CcSEcCtD
Conjugated Estrogens—Nausea—Cyclosporine—psoriasis	2.21e-05	0.000213	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Prednisone—psoriasis	2.21e-05	0.000213	CcSEcCtD
Conjugated Estrogens—ABCC3—Metabolism—NDUFA5—psoriasis	2.2e-05	0.00162	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Triamcinolone—psoriasis	2.2e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—psoriasis	2.2e-05	0.000212	CcSEcCtD
Conjugated Estrogens—Dizziness—Hydrocortisone—psoriasis	2.18e-05	0.00021	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—psoriasis	2.18e-05	0.00021	CcSEcCtD
Conjugated Estrogens—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.17e-05	0.0016	CbGpPWpGaD
Conjugated Estrogens—Dyspepsia—Prednisone—psoriasis	2.16e-05	0.000208	CcSEcCtD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	2.16e-05	0.0016	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—IL10—psoriasis	2.16e-05	0.00159	CbGpPWpGaD
Conjugated Estrogens—Nausea—Mycophenolate mofetil—psoriasis	2.15e-05	0.000207	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—psoriasis	2.14e-05	0.000206	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—psoriasis	2.14e-05	0.000206	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—psoriasis	2.14e-05	0.000206	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Prednisone—psoriasis	2.14e-05	0.000206	CcSEcCtD
Conjugated Estrogens—Rash—Prednisolone—psoriasis	2.13e-05	0.000205	CcSEcCtD
Conjugated Estrogens—Dermatitis—Prednisolone—psoriasis	2.13e-05	0.000205	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.13e-05	0.000205	CcSEcCtD
Conjugated Estrogens—Fatigue—Prednisone—psoriasis	2.12e-05	0.000204	CcSEcCtD
Conjugated Estrogens—Headache—Prednisolone—psoriasis	2.12e-05	0.000204	CcSEcCtD
Conjugated Estrogens—Constipation—Prednisone—psoriasis	2.1e-05	0.000202	CcSEcCtD
Conjugated Estrogens—Vomiting—Hydrocortisone—psoriasis	2.1e-05	0.000202	CcSEcCtD
Conjugated Estrogens—ABCB1—Allograft Rejection—IL4—psoriasis	2.1e-05	0.00155	CbGpPWpGaD
Conjugated Estrogens—Rash—Hydrocortisone—psoriasis	2.08e-05	0.000201	CcSEcCtD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.08e-05	0.00154	CbGpPWpGaD
Conjugated Estrogens—Dermatitis—Hydrocortisone—psoriasis	2.08e-05	0.0002	CcSEcCtD
Conjugated Estrogens—ESR1—Leptin signaling pathway—NFKB1—psoriasis	2.08e-05	0.00153	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CYP2S1—psoriasis	2.07e-05	0.00153	CbGpPWpGaD
Conjugated Estrogens—Headache—Hydrocortisone—psoriasis	2.07e-05	0.000199	CcSEcCtD
Conjugated Estrogens—Dizziness—Triamcinolone—psoriasis	2.06e-05	0.000198	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—psoriasis	2.05e-05	0.000198	CcSEcCtD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.05e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.05e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.05e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	2.04e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.04e-05	0.00151	CbGpPWpGaD
Conjugated Estrogens—Infection—Methotrexate—psoriasis	2.04e-05	0.000197	CcSEcCtD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—VDR—psoriasis	2.04e-05	0.0015	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	2.03e-05	0.0015	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.03e-05	0.0015	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Dexamethasone—psoriasis	2.02e-05	0.000195	CcSEcCtD
Conjugated Estrogens—Asthenia—Betamethasone—psoriasis	2.02e-05	0.000195	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—psoriasis	2.01e-05	0.000194	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Prednisone—psoriasis	2.01e-05	0.000194	CcSEcCtD
Conjugated Estrogens—Nausea—Prednisolone—psoriasis	2.01e-05	0.000194	CcSEcCtD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	2.01e-05	0.00148	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Betamethasone—psoriasis	2e-05	0.000192	CcSEcCtD
Conjugated Estrogens—Pruritus—Dexamethasone—psoriasis	2e-05	0.000192	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—psoriasis	1.99e-05	0.000192	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—psoriasis	1.99e-05	0.000191	CcSEcCtD
Conjugated Estrogens—Vomiting—Triamcinolone—psoriasis	1.98e-05	0.00019	CcSEcCtD
Conjugated Estrogens—Nausea—Hydrocortisone—psoriasis	1.96e-05	0.000189	CcSEcCtD
Conjugated Estrogens—Rash—Triamcinolone—psoriasis	1.96e-05	0.000189	CcSEcCtD
Conjugated Estrogens—Dermatitis—Triamcinolone—psoriasis	1.96e-05	0.000189	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—psoriasis	1.96e-05	0.000189	CcSEcCtD
Conjugated Estrogens—Urticaria—Prednisone—psoriasis	1.95e-05	0.000188	CcSEcCtD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.95e-05	0.00144	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	1.95e-05	0.00144	CbGpPWpGaD
Conjugated Estrogens—Headache—Triamcinolone—psoriasis	1.95e-05	0.000188	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Prednisone—psoriasis	1.94e-05	0.000187	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Prednisone—psoriasis	1.94e-05	0.000187	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Dexamethasone—psoriasis	1.93e-05	0.000186	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Betamethasone—psoriasis	1.93e-05	0.000186	CcSEcCtD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	1.92e-05	0.00142	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Methotrexate—psoriasis	1.92e-05	0.000185	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism—NDUFA5—psoriasis	1.92e-05	0.00141	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	1.91e-05	0.00141	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	1.91e-05	0.00141	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—HLA-A—psoriasis	1.9e-05	0.0014	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	1.88e-05	0.00138	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CYP2S1—psoriasis	1.87e-05	0.00138	CbGpPWpGaD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—psoriasis	1.87e-05	0.00018	CcSEcCtD
Conjugated Estrogens—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.87e-05	0.00138	CbGpPWpGaD
Conjugated Estrogens—ESR1—Leptin signaling pathway—STAT3—psoriasis	1.87e-05	0.00138	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Dexamethasone—psoriasis	1.87e-05	0.00018	CcSEcCtD
Conjugated Estrogens—Dizziness—Betamethasone—psoriasis	1.87e-05	0.00018	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—psoriasis	1.86e-05	0.000179	CcSEcCtD
Conjugated Estrogens—Nausea—Triamcinolone—psoriasis	1.85e-05	0.000178	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—psoriasis	1.84e-05	0.000178	CcSEcCtD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.83e-05	0.00135	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	1.83e-05	0.00135	CbGpPWpGaD
Conjugated Estrogens—Dyspnoea—Methotrexate—psoriasis	1.83e-05	0.000176	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—psoriasis	1.83e-05	0.000176	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Prednisone—psoriasis	1.81e-05	0.000174	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—psoriasis	1.81e-05	0.000174	CcSEcCtD
Conjugated Estrogens—Vomiting—Dexamethasone—psoriasis	1.79e-05	0.000173	CcSEcCtD
Conjugated Estrogens—Vomiting—Betamethasone—psoriasis	1.79e-05	0.000173	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.79e-05	0.00132	CbGpPWpGaD
Conjugated Estrogens—Decreased appetite—Methotrexate—psoriasis	1.79e-05	0.000172	CcSEcCtD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—TNF—psoriasis	1.78e-05	0.00132	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	1.78e-05	0.00131	CbGpPWpGaD
Conjugated Estrogens—Rash—Dexamethasone—psoriasis	1.78e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Rash—Betamethasone—psoriasis	1.78e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Dermatitis—Betamethasone—psoriasis	1.78e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Dermatitis—Dexamethasone—psoriasis	1.78e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—psoriasis	1.77e-05	0.000171	CcSEcCtD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.77e-05	0.00131	CbGpPWpGaD
Conjugated Estrogens—Fatigue—Methotrexate—psoriasis	1.77e-05	0.000171	CcSEcCtD
Conjugated Estrogens—Headache—Dexamethasone—psoriasis	1.77e-05	0.00017	CcSEcCtD
Conjugated Estrogens—Headache—Betamethasone—psoriasis	1.77e-05	0.00017	CcSEcCtD
Conjugated Estrogens—Asthenia—Prednisone—psoriasis	1.76e-05	0.00017	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—psoriasis	1.76e-05	0.000169	CcSEcCtD
Conjugated Estrogens—Pruritus—Prednisone—psoriasis	1.74e-05	0.000167	CcSEcCtD
Conjugated Estrogens—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	1.74e-05	0.00128	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.74e-05	0.00128	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NDUFA5—psoriasis	1.72e-05	0.00127	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—CARM1—psoriasis	1.72e-05	0.00127	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	1.7e-05	0.00125	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Prednisone—psoriasis	1.68e-05	0.000162	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—psoriasis	1.68e-05	0.000162	CcSEcCtD
Conjugated Estrogens—Nausea—Dexamethasone—psoriasis	1.68e-05	0.000161	CcSEcCtD
Conjugated Estrogens—Nausea—Betamethasone—psoriasis	1.68e-05	0.000161	CcSEcCtD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	1.67e-05	0.00123	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—CARM1—psoriasis	1.64e-05	0.00121	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NDUFA5—psoriasis	1.64e-05	0.00121	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Methotrexate—psoriasis	1.63e-05	0.000157	CcSEcCtD
Conjugated Estrogens—SLCO1A2—Metabolism—CYP2S1—psoriasis	1.63e-05	0.0012	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Prednisone—psoriasis	1.62e-05	0.000157	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—psoriasis	1.62e-05	0.000156	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—psoriasis	1.62e-05	0.000156	CcSEcCtD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	1.62e-05	0.0012	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—CARM1—psoriasis	1.62e-05	0.00119	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.61e-05	0.00119	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	1.6e-05	0.00118	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	1.6e-05	0.00118	CbGpPWpGaD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—IL6—psoriasis	1.58e-05	0.00117	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Prednisone—psoriasis	1.56e-05	0.000151	CcSEcCtD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.56e-05	0.00115	CbGpPWpGaD
Conjugated Estrogens—Rash—Prednisone—psoriasis	1.55e-05	0.000149	CcSEcCtD
Conjugated Estrogens—Dermatitis—Prednisone—psoriasis	1.55e-05	0.000149	CcSEcCtD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	1.55e-05	0.00114	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.54e-05	0.00114	CbGpPWpGaD
Conjugated Estrogens—Headache—Prednisone—psoriasis	1.54e-05	0.000148	CcSEcCtD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	1.53e-05	0.00113	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.53e-05	0.00113	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	1.52e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.52e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NDUFA5—psoriasis	1.52e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—TYK2—psoriasis	1.52e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Methotrexate—psoriasis	1.51e-05	0.000146	CcSEcCtD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.51e-05	0.00112	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—TP53—psoriasis	1.51e-05	0.00111	CbGpPWpGaD
Conjugated Estrogens—Asthenia—Methotrexate—psoriasis	1.47e-05	0.000142	CcSEcCtD
Conjugated Estrogens—ABCC1—Metabolism—CYP2S1—psoriasis	1.47e-05	0.00108	CbGpPWpGaD
Conjugated Estrogens—Nausea—Prednisone—psoriasis	1.46e-05	0.000141	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—psoriasis	1.45e-05	0.00014	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	1.45e-05	0.00107	CbGpPWpGaD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—IL6—psoriasis	1.44e-05	0.00106	CbGpPWpGaD
Conjugated Estrogens—ESR2—Generic Transcription Pathway—PPARG—psoriasis	1.42e-05	0.00105	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	1.41e-05	0.00104	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Methotrexate—psoriasis	1.41e-05	0.000135	CcSEcCtD
Conjugated Estrogens—SLCO1B1—Metabolism—CYP2S1—psoriasis	1.39e-05	0.00103	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—IL6—psoriasis	1.38e-05	0.00102	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Methotrexate—psoriasis	1.36e-05	0.000131	CcSEcCtD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.35e-05	0.000995	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	1.35e-05	0.000992	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.34e-05	0.000987	CbGpPWpGaD
Conjugated Estrogens—Vomiting—Methotrexate—psoriasis	1.31e-05	0.000126	CcSEcCtD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.3e-05	0.000958	CbGpPWpGaD
Conjugated Estrogens—Rash—Methotrexate—psoriasis	1.29e-05	0.000125	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—psoriasis	1.29e-05	0.000125	CcSEcCtD
Conjugated Estrogens—ABCG2—Metabolism—CYP2S1—psoriasis	1.29e-05	0.000952	CbGpPWpGaD
Conjugated Estrogens—Headache—Methotrexate—psoriasis	1.29e-05	0.000124	CcSEcCtD
Conjugated Estrogens—ABCB1—Allograft Rejection—IFNG—psoriasis	1.27e-05	0.000935	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.27e-05	0.000933	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CARM1—psoriasis	1.24e-05	0.000914	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.23e-05	0.00091	CbGpPWpGaD
Conjugated Estrogens—Nausea—Methotrexate—psoriasis	1.22e-05	0.000118	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling Pathways—HCAR2—psoriasis	1.22e-05	0.000899	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.19e-05	0.000876	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.18e-05	0.00087	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.18e-05	0.000869	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.11e-05	0.000816	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.09e-05	0.000802	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.08e-05	0.000795	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.06e-05	0.000782	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TAGAP—psoriasis	1.06e-05	0.00078	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—VDR—psoriasis	1.03e-05	0.000758	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.02e-05	0.000754	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CARM1—psoriasis	1.01e-05	0.000747	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.01e-05	0.000745	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.01e-05	0.000745	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—CAT—psoriasis	9.95e-06	0.000734	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	9.84e-06	0.000726	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.81e-06	0.000723	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—VDR—psoriasis	9.8e-06	0.000723	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	9.71e-06	0.000716	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—VEGFA—psoriasis	9.57e-06	0.000706	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.47e-06	0.000698	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—NOS2—psoriasis	9.44e-06	0.000696	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CARM1—psoriasis	9.14e-06	0.000674	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.93e-06	0.000659	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.54e-06	0.00063	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.54e-06	0.00063	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—CARM1—psoriasis	8.28e-06	0.000611	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Allograft Rejection—TNF—psoriasis	8.2e-06	0.000605	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NDUFA5—psoriasis	8.2e-06	0.000605	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.16e-06	0.000602	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	8.14e-06	0.000601	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CARM1—psoriasis	7.96e-06	0.000587	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—APOE—psoriasis	7.73e-06	0.00057	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.68e-06	0.000567	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.65e-06	0.000565	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CAT—psoriasis	7.62e-06	0.000562	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	7.62e-06	0.000562	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.44e-06	0.000549	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—IL6—psoriasis	7.41e-06	0.000547	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.3e-06	0.000539	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	7.27e-06	0.000537	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CARM1—psoriasis	7.16e-06	0.000528	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—PPARG—psoriasis	7.16e-06	0.000528	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP2S1—psoriasis	6.97e-06	0.000515	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—PPARG—psoriasis	6.83e-06	0.000504	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CARM1—psoriasis	6.8e-06	0.000502	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.75e-06	0.000498	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PPARG—psoriasis	6.73e-06	0.000497	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.69e-06	0.000494	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NDUFA5—psoriasis	6.55e-06	0.000483	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.36e-06	0.000469	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCL20—psoriasis	6.33e-06	0.000467	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CARM1—psoriasis	6.3e-06	0.000465	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CAT—psoriasis	6.23e-06	0.00046	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.11e-06	0.00045	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—APOE—psoriasis	5.92e-06	0.000437	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CAT—psoriasis	5.62e-06	0.000415	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP2S1—psoriasis	5.57e-06	0.000411	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—VEGFA—psoriasis	5.47e-06	0.000403	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.41e-06	0.000399	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.21e-06	0.000384	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PPARG—psoriasis	5.16e-06	0.000381	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NDUFA5—psoriasis	5.05e-06	0.000373	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—VDR—psoriasis	4.94e-06	0.000365	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CAT—psoriasis	4.89e-06	0.000361	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—APOE—psoriasis	4.84e-06	0.000357	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.72e-06	0.000349	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CAT—psoriasis	4.4e-06	0.000325	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HLA-A—psoriasis	4.38e-06	0.000323	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—APOE—psoriasis	4.37e-06	0.000322	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP2S1—psoriasis	4.3e-06	0.000317	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PPARG—psoriasis	4.22e-06	0.000311	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CAT—psoriasis	4.18e-06	0.000309	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—psoriasis	4.13e-06	0.000305	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—APOE—psoriasis	4.09e-06	0.000301	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.05e-06	0.000299	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CAT—psoriasis	3.87e-06	0.000286	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NOS2—psoriasis	3.81e-06	0.000281	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PPARG—psoriasis	3.8e-06	0.000281	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—APOE—psoriasis	3.8e-06	0.000281	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.57e-06	0.000263	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SOCS1—psoriasis	3.49e-06	0.000257	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—PPARG—psoriasis	3.45e-06	0.000254	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—APOE—psoriasis	3.42e-06	0.000252	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CARM1—psoriasis	3.41e-06	0.000251	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PPARG—psoriasis	3.31e-06	0.000244	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—APOE—psoriasis	3.25e-06	0.00024	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TYK2—psoriasis	3.12e-06	0.00023	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—APOE—psoriasis	3.01e-06	0.000222	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PPARG—psoriasis	2.98e-06	0.00022	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.92e-06	0.000215	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PPARG—psoriasis	2.83e-06	0.000209	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CD4—psoriasis	2.82e-06	0.000208	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CARM1—psoriasis	2.72e-06	0.000201	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PPARG—psoriasis	2.62e-06	0.000193	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—LEP—psoriasis	2.57e-06	0.00019	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—APOE—psoriasis	2.57e-06	0.00019	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.54e-06	0.000188	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NFKBIA—psoriasis	2.4e-06	0.000177	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—STAT3—psoriasis	2.18e-06	0.000161	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CARM1—psoriasis	2.1e-06	0.000155	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CAT—psoriasis	2.1e-06	0.000155	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TYK2—psoriasis	1.96e-06	0.000145	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—psoriasis	1.71e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CAT—psoriasis	1.67e-06	0.000123	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—APOE—psoriasis	1.63e-06	0.00012	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JUN—psoriasis	1.59e-06	0.000117	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NFKB1—psoriasis	1.53e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—psoriasis	1.53e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPARG—psoriasis	1.42e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—VEGFA—psoriasis	1.39e-06	0.000102	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—STAT3—psoriasis	1.37e-06	0.000101	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—APOE—psoriasis	1.3e-06	9.59e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CAT—psoriasis	1.29e-06	9.52e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPARG—psoriasis	1.13e-06	8.35e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—psoriasis	1.05e-06	7.74e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—APOE—psoriasis	1e-06	7.4e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—psoriasis	9.6e-07	7.08e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPARG—psoriasis	8.74e-07	6.44e-05	CbGpPWpGaD
